Cancer Diagnosis in China: AI Pathology Model Identifies Tumors in 1 Second

For patients traveling abroad for cancer care, the speed and accuracy of diagnosis can shape the entire treatment journey. A delayed or uncertain pathology report can mean weeks of anxiety before a treatment plan even begins. Now, a new AI pathology model developed at Zhejiang University and its affiliated First Hospital promises to cut that waiting time dramatically—reportedly identifying cancer lesions in as little as one second.

AI Pathology Model Aims to Speed Up Cancer Diagnosis in China

According to a report by Zhejiang Satellite TV, Zhejiang University has officially released a large-scale artificial intelligence model designed specifically for pathology. The system, developed in collaboration with the First Affiliated Hospital of Zhejiang University School of Medicine (Zhejiang University First Hospital), is capable of analyzing digital pathology slides and pinpointing cancerous lesions with remarkable speed.

The news segment highlighted that this AI pathology model can lock onto cancer foci in as fast as one second. While traditional manual review of pathology slides by a pathologist can be time-consuming and subject to human fatigue, this AI-driven approach offers a powerful supplementary tool. The model has been trained on vast datasets of pathological images, enabling it to recognize subtle morphological patterns associated with various malignancies.

How the AI Pathology Model Works

The AI system functions by scanning digitized whole-slide images—high-resolution representations of tissue samples placed on glass slides. Using deep learning algorithms, the model analyzes cellular structures, tissue architecture, and staining patterns to detect abnormalities indicative of cancer. The report from Zhejiang Satellite TV emphasized the model’s ability to rapidly highlight regions of interest for pathologists, effectively serving as a first-pass screening mechanism.

This does not replace the pathologist but rather augments their workflow. By pre-screening slides and flagging suspicious areas, the AI allows specialists to focus their expertise on the most critical regions, potentially reducing overall diagnostic turnaround times. Research from the National Cancer Institute has similarly explored how AI tools can assist pathologists in improving diagnostic accuracy and efficiency.

Clinical Significance and Hospital Integration

The development was announced in early 2025 and has drawn attention from national media outlets. Zhejiang University First Hospital, a leading medical institution in eastern China, is at the forefront of integrating such technologies into clinical practice. The hospital’s pathology department has been actively involved in the research and validation of the model, underscoring a commitment to translating laboratory breakthroughs into bedside benefits.

For patients, this means that the initial detection of cancer from biopsy or surgical specimens could become significantly faster. In cases where time is critical—such as aggressive tumors requiring immediate intervention—even a reduction of a few days in the diagnostic process can have meaningful clinical impact. Cancer diagnosis and treatment planning often hinge on the timely availability of pathology results.

While specific performance metrics such as sensitivity and specificity were not detailed in the television segment, the announcement signals a broader trend in Chinese hospitals: the systematic adoption of AI to enhance diagnostic services. The World Health Organization has noted the growing role of digital health technologies in improving cancer care delivery worldwide.

For international patients considering getting medical care in China as a foreigner, the availability of AI-assisted pathology may offer reassurance that diagnostic processes are keeping pace with global innovations. The model’s development at a major university hospital reflects the integration of academic research with clinical application—a factor that can influence decisions when evaluating treatment destinations.

Source: 浙大一院

Reviewed by ToChinaMed. Published: 2025-06-17. This article is based on publicly available medical news and is not a substitute for professional medical advice.

ToChinaMed helps international patients find reliable medical treatment in China.

What This Means for Patients

For international patients considering treatment in China, this development reflects the growing depth of expertise available in Chinese medical centers. Discuss your specific condition with a qualified specialist to understand if these advances apply to your situation.